George Washington University School of Medicine, Washington, DC.
Arthritis Care Res (Hoboken). 2013 Dec;65(12):1969-75. doi: 10.1002/acr.22088.
To differentiate juvenile polymyositis (PM) and muscular dystrophy, both of which may present with chronic muscle weakness and inflammation.
We studied 39 patients with probable or definite juvenile PM and 9 patients with muscular dystrophies who were initially misdiagnosed as having juvenile PM. Differences in demographic, clinical, and laboratory results; outcomes; and treatment responses were evaluated by Fisher's exact and rank sum tests. Random forests classification analysis and logistic regression were performed to examine significant differences in multivariable models.
Clinical features and serum muscle enzyme levels were similar between juvenile PM and dystrophy patients, except 89% of dystrophy patients had muscle atrophy compared with 46% of juvenile PM patients. Dystrophy patients had a longer delay to diagnosis (median 12 versus 4 months) and were less frequently hospitalized than juvenile PM patients (22% versus 74%). No dystrophy patients, but 54% of juvenile PM patients, had a myositis autoantibody. Dystrophy patients more frequently had myopathic features on muscle biopsy, including diffuse variation of myofiber size, fiber hypertrophy, and myofiber fibrosis (44-100% versus 8-53%). Juvenile PM patients more frequently had complex repetitive discharges on electromyography and a complete response to treatment with prednisone or other immunosuppressive agents than dystrophy patients (44% versus 0%). Random forests analysis revealed that the most important features in distinguishing juvenile PM from dystrophies were myositis autoantibodies, clinical muscle atrophy, and myofiber size variation on biopsy. Logistic regression confirmed muscle atrophy, myofiber fibrosis, and hospitalization as significant predictors.
Muscular dystrophy can present similarly to juvenile PM. Selected clinical and laboratory features are helpful in combination in distinguishing these conditions.
区分幼年型皮肌炎(PM)和肌营养不良症,这两种疾病都可能表现为慢性肌肉无力和炎症。
我们研究了 39 例可能或明确的幼年型 PM 患者和 9 例最初误诊为幼年型 PM 的肌营养不良症患者。通过 Fisher 确切检验和秩和检验评估了人口统计学、临床和实验室结果、结局以及治疗反应的差异。采用随机森林分类分析和逻辑回归对多变量模型进行了显著性差异检验。
除了 89%的肌营养不良症患者存在肌肉萎缩,而 46%的幼年型 PM 患者存在肌肉萎缩外,幼年型 PM 和肌营养不良症患者的临床特征和血清肌肉酶水平相似。肌营养不良症患者的诊断延迟时间更长(中位数为 12 个月 vs. 4 个月),住院率低于幼年型 PM 患者(22% vs. 74%)。没有肌营养不良症患者,而 54%的幼年型 PM 患者存在肌炎自身抗体。肌营养不良症患者的肌肉活检更常出现肌病特征,包括肌纤维大小的弥漫性变化、纤维肥大和肌纤维纤维化(44-100% vs. 8-53%)。与肌营养不良症患者相比,幼年型 PM 患者更常出现肌电图上的复杂重复放电,并且对泼尼松或其他免疫抑制剂治疗有完全反应(44% vs. 0%)。随机森林分析显示,鉴别幼年型 PM 和肌营养不良症最重要的特征是肌炎自身抗体、临床肌肉萎缩和活检上的肌纤维大小变化。逻辑回归证实肌肉萎缩、肌纤维纤维化和住院治疗是重要的预测指标。
肌营养不良症可以与幼年型 PM 相似表现。选择的临床和实验室特征有助于联合区分这些疾病。